Search for melanoma markers in plasma and serum samples

European Journal of Mass Spectrometry

Volumn 11, Issue 3, 2005, Pages 353-360

  Seraglia, Roberta ^a   Vogliardi, Susanna ^a   Allegri, Graziella ^b   Comai, Stefano ^b   Lise, Mario ^b   Rossi, Carlo Riccardo ^b   Mocellin, Simone ^b   Scalerta, Romano ^b   Ragazzi, Eugenio ^c   Traldi, Pietro ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Dipartimento di Farmacologia   (Italy)

Author keywords

Human plasma; Human serum; MALDI; Mass spectrometry; Melanomas

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CALIBRATION; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; MELANOMA; MIDDLE AGED;

ADULT; AGED; CALIBRATION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 24144458243     PISSN: 14690667     EISSN: None     Source Type: Journal    
DOI: 10.1255/ejms.751     Document Type: Article

References (29)

1. D.R. Boggs and J.L. Fahey, "Serum-protein changes in malignant disease. II. The chronic leukemias. Hodgkin's disease and malignant melanoma", J. Natl. Cancer Inst. 25, 1381 (1960).
2. J.L. Fahey and D.R. Boggs, "Serum protein changes in malignant diseases. I. The acute leukemias", Blood 16, 1479 (1960).
3. K.J. Tomecki, P.M. Montagne and V.I. Hearing, "Serum and urine protein differences in patients with malignant melanoma", J. Natl.Cancer Inst. 64, 29 (1980).
4. V.J. Hearing, A.E. Newburger, T.M. Ekel and P.M. Montagne, "Malignant melanoma-Abnormal proteins synthesized in murine and human tissues", Pigment Cell Vol. 9. University Tokyo Press, Tokyo, Japan, p. 113 (1981).
5. K.R. Clauser, S.C. Hall, D.M. Smith, J.W. Webb, L.E. Andrews, H.M. Tran, L.B. Epstein and A.L.Burlingame, "Rapid mass spectrometric peptide sequencing and mass matching for characterization of human melanoma proteins isolated by two-dimensional PAGE", Proc. Natl. Acad. Sci. USA 92, 5072 (1995).
6. H.B. Guo, B. Stoffel-Wagner, T. Bierwith, J. Mezger and D. Klingmuller, "Clinical significance of serum S100 in metastatic malignant melanoma", Eur. J. Cancer 31A, 924 (1995).
7. G. Henze, R. Dummer, H.I. Joller-Jemelka, R. Boni and G. Burg, "Serum S-100 - A marker for disease monitoring in metastatic melanoma", Dermatology 194, 208 (1997).
8. H.D. Abraha, L.C. Fuller, A.W. Du Vivier, E.M. Higgins and R.A. Sherwood, "Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma", Brit. J. Dermatol. 137, 381 (1997).
9. O.C. Fagnart, C.M. Sindic and C. Laterre, "Particle counting immunoassay of S100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system", Clin. Chem. 34, 1387 (1988).
10. D. Kilgman and D.C. Hilt, "The S100 protein family", TIBS 13, 437 (1988).
11. T. Isobe, N. Ishioka, T. Matsuda, Y. Takahashi, S. Ganno and T. Okuyama, "A rapid separation of S100 subunits by high performance liquid chromatography: the subunit compositions of S100 proteins", Biochem. Int. 6, 419 (1983).
12. H. Haimoto, S. Hosada and K. Kato, "Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal nonnervous human tissues", Lab. Invest. 57, 489 (1987).
13. A. Marks and R. Allore, "S100 protein and Down syndrome", Bioessays 12, 381 (1990).
14. H.D. Abraha, P.L. Noble, K.H. Nicolaides and R.A. Sherwood, "Maternal serum S100 protein in normal and Down syndrome pregnancies", Prenat. Diagn. 19, 334 (1999).
15. R. Molina, J. Navarro, X. Filella, T. Castel and A.M. Ballesta, "S-100 protein serum levels in patients with benign and malignant diseases: false-positive results related to liver and renal function", Tumour Biol. 23, 39 (2002).
16. K. Acland, E.V. Evans, H. Abraha, C.M. Healy, P. Roblin, E. Calonje, G. Orchard, E. Higgins, R. Sherwood and R. Russel-Jones, "Serum S100 concentrations are not useful in predicting micrometastatic disease in cutaneous malignant melanoma", Br. J. Dermatol. 146, 832 (2002).
17. I. Camby, N. Nagy, M.B. Lopes, B.W. Schafer, C.A. Maurage, M.M. Ruchoux, P. Murmann, R. Pochet, C.W. Heizmann, J. Brotchi, I. Salmon, R. Kiss and C. Decaestecker, "Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins", Brain Pathol. 9, 1 (1999).
18. T. Stigbrand, L. Nyberg, A. Ullen, K. Haglid, E. Sandstrom and J. Brundell, "A new specific method for measuring S-100B in serum", Int. J. Biol. Markers 15, 33 (2000).
19. A. Regner, M. Kaufman, G. Friedman and I. Chemale, "Increased serum S100beta protein concentrations following severe head injury in humans: a biochemical marker of brain death?", Neuroreport 12, 691 (2001).
20. A. Petzold, A.J.E. Green, G. Keir, S. Fairley, N. Kitchen, M. Smith and E.J. Thompson, "Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: a pilot study", Critical Care Medicine 30, 2705 (2002).
21. D.A. Chatfield, F.P. Zemlan, D.J. Day and D.K. Menon, "Discordant temporal patterns of S100beta and cleaved tau protein elevation after head injury: a pilot study", Brit. J. Neurosurg. 16, 471 (2002).
22. L. Ferrari, R. Seraglia, C.R. Rossi, A. Bertazzo, M. Lise, G. Allegri and P. Traldi, "Protein profiles in sera of patients with malignant cutaneous melanoma", Rapid Commun. Mass Spectrom. 14, 1149 (2000).
23. E. Ragazzi, S. Vogliardi, G. Allegri, C.V.L. Costa, M. Lise, C.R. Rossi, R. Seraglia and P. Traldi, "Cluster analysis of serum proteins in malignant cutaneous melanoma: search for disease markers", Rapid Commun. Mass Spectrom. 17, 1511 (2003).
24. U. Wollina, K. Karte, U.C. Hipler, B. Knoll, K. Kirsch and C. Herold, "Serum protein s100beta in patients with malignant melanoma detected by an immunoluminometric assay", J. Cancer Res. Clin. Oncol. 126, 107 (2000).
25. A. Hauschild, R. Glaser and E. Christophers, "Quantification of melanoma-associated molecules in plasma/serum of melanoma patients", Recent Results Cancer Res. 158, 169 (2001).
26. E.D. Martenson, L.O. Hansson, B. Nilsson, E. von Schoultz, E. Mansson-Brahme, U. Ringborg and J. Hansson, "Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma", J. Clin. Oncol. 19, 824 (2001).
27. T. Banfalvi, K. Gilde, M. Gergye, M. Boldizsar, T. Kremer and S. Otto, "Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma", Eur. J. Cancer 39, 164 (2003).
28. R. Seraglia, E. Ragazzi, S. Vogliardi, G. Allegri, S. Pucciarelli, M. Agostini, M. Lise, D. Nitti, E.D. Urso and P. Traldi, "Search of plasma markers for colorectal cancer by matrix-assisted laser desorption/ionization mass spectrometry", J. Mass Spectrom. 40, 123 (2005).
29. L.R. Crawford and J.D. Morrison, "Computer methods in analytical mass spectrometry. Identification of an unknown compound in a catalog", Anal. Chem. 40, 1465 (1968).